Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Biogen Idec and Genentech Announce Restructuring of anti-CD20 Collaboration Agreement
Histologie de la sclerose en plaques
Unusual association of Arnold-Chiari malformation and vitamin B12 deficiency.
A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis.
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison.
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany.
A Study of Efficacy and Safety of Ocrelizumab in Patients with Relapse-Remitting Multiple Sclerosis
New therapies in the management of rheumatoid arthritis.
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.
Safety study of BIIB033 in subjects with multiple sclerosis
Efficacy and Safety of GTR in Comparison to Copaxone® (GATE)
Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists.
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.
Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica: Multicenter Study of Treatment Efficacy.
Development of oral immunomodulatory agents in the management of multiple sclerosis.
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
LINGO-1 negatively regulates myelination by oligodendrocytes.
Immunomodulatory agents and risk of postpartum multiple sclerosis relapses.
Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis.
Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis.
Ocrelizumab Bests Interferon in Relapsing-Remitting MS
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.

Pages